Qube Research & Technologies Ltd

SEC CIK: 0001729829
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 221,607
Value: $138.2M
% of portfolio: 0.2%
Quarters held: 19; Since Q3 2021

Holdings of REGN by Qube Research & Technologies Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	221,607	$138.2M	0.2%	+138,249+165.8%	Added	Holders
Q1 2026	83,358	$64.4M	0.1%	−58,825−41.4%	Reduced	Holders
Q4 2025	142,183	$109.7M	0.2%	−406,551−74.1%	Reduced	Holders
Q3 2025	548,734	$308.5M	0.4%	−77,246−12.3%	Reduced	Holders
Q2 2025	625,980	$328.6M	0.5%	−76,912−10.9%	Reduced	Holders
Q1 2025	702,892	$445.8M	0.7%	+261,238+59.1%	Added	Holders
Q4 2024	441,654	$314.6M	0.5%	+289,685+190.6%	Added	Holders
Q3 2024	151,969	$159.8M	0.3%	−41,979−21.6%	Reduced	Holders
Q2 2024	193,948	$203.8M	0.4%	+38,100+24.4%	Added	Holders
Q1 2024	155,848	$150.0M	0.3%	−15,516−9.1%	Reduced	Holders
Q4 2023	171,364	$150.5M	0.3%	+165,621+2,883.9%	Added	Holders
Q3 2023	5,743	$4.73M	<0.1%	+5,743	New	Holders
Q2 2023	0	$0	0.0%	−4,519−100.0%	Sold out	Holders
Q1 2023	4,519	$3.71M	<0.1%	−102,160−95.8%	Reduced	Holders
Q4 2022	106,679	$77.0M	0.5%	+98,996+1,288.5%	Added	Holders
Q3 2022	7,683	$5.29M	<0.1%	−75,067−90.7%	Reduced	Holders
Q2 2022	82,750	$48.9M	0.4%	+73,120+759.3%	Added	Holders
Q1 2022	9,630	$6.73M	0.1%	−11,030−53.4%	Reduced	Holders
Q4 2021	20,660	$13.0M	0.1%	−15,985−43.6%	Reduced	Holders
Q3 2021	36,645	$22.2M	0.3%	+36,645	New	Holders